The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsHealth
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete...
About This Episode
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent e...
Podcast
This episode belongs to FDA Drug Information Updates.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 18, 2017, 00:05:59 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Information Updates.
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
May 4, 2018 - 00:02:59
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Jan 7, 2018 - 00:08:29
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
Jan 5, 2018 - 00:02:59
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Oct 29, 2017 - 00:09:22
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Aug 17, 2017 - 00:05:29
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Jul 28, 2017 - 00:06:00
Questions About This Episode
What is FDA D.I.S.C.O.: Niraparib in Ovarian Cancer about?
FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy. Released May 18, 2017
Where can I listen to FDA D.I.S.C.O.: Niraparib in Ovarian Cancer?
You can listen to FDA D.I.S.C.O.: Niraparib in Ovarian Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA D.I.S.C.O.: Niraparib in Ovarian Cancer from?
FDA D.I.S.C.O.: Niraparib in Ovarian Cancer is an episode from FDA Drug Information Updates by ReachMD.
How long is this episode?
This episode is 00:05:59 long.
When was this episode published?
This episode was published on May 18, 2017.
Can I save FDA D.I.S.C.O.: Niraparib in Ovarian Cancer for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Information Updates?
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.